European Respiratory Society Calls for Tobacco End Game
The ERS is urging European countries to adopt "tobacco endgame" policies to permanently reduce tobacco use and end the epidemic.
Tag: ERS European Respiratory Society
All
Latest
European Respiratory Society Calls for Tobacco End Game
The ERS is urging European countries to adopt “tobacco endgame” policies to permanently reduce tobacco use and end the epidemic.
Read More
Bronchiectasis and NTM Research Registry Data Presented at ERS 2025
The European Respiratory Society Congress featured two abstracts using data from the Bronchiectasis and NTM Research Registry.
Read More
ELF Honors ‘Our Kids’ Climate’ for Protecting Respiratory Health
Our Kids’ Climate has been awarded the 2025 European Lung Foundation (ELF) Award for its outstanding contribution to safeguarding children’s respiratory health worldwide.
Read More
Prioritizing Prevention of Chronic Respiratory Diseases
ERS leaders are calling for health systems to prioritize and integrate the care of chronic respiratory diseases (CRDs) across Europe.
Read More
New Guidelines Recommend Shorter All-Oral TB Treatment Regimens
The latest clinical practice guidelines advocate for four- and six-month all-oral regimens for eligible children and adults with drug-susceptible or drug-resistant tuberculosis.
Read More
Over-the-counter Treatment Cuts Common Cold by Two Days in Kids
Researchers found the treatment also reduced the spread of colds to family members.
Read More
Long-Term Air Pollution Exposure Increases Respiratory Hospitalizations
Also, researchers link traffic-related air pollution to asthmatic patients developing COPD.
Read More
Young Vapers Show Similar Exercise Limitations as Smokers
A study found that young people who vape have reduced exercise capacity similar to that of young smokers.
Read More
Vaping Predicted to Have Notable Impact on Europe’s COPD Burden
Research predicts that vaping—in addition to smoking and air pollution—will increase the burden of COPD in Western Europe by 2050, while home NIV is expected to reduce mortality from COPD exacerbations.
Read More
Smoking Before 18 Tied to Increased Respiratory Symptoms in Young Adults
People who start smoking before age 18 are more likely to experience respiratory symptoms, such as wheezing and phlegm, in their 20s.
Read More
Genetic Risk for COPD Linked to Lower Lung Function from Childhood
A new study finds individuals with higher genetic risk for COPD show lower lung function starting in childhood.
Read More
Transplanting COPD Patients’ Own Cells Restores Lung Function
Researchers have shown it is possible to repair damaged lung tissue in patients with chronic obstructive pulmonary disease using the patients’ own lung cells.
Read More
CPAP Cuts OSA Patients’ Cardiovascular Death Risk by 36%
A small patient trial also suggests CPAP may be more effective than a weight-loss drug in tackling clogged arteries.
Read More
World No Tobacco Day: The Environmental Impact of Smoking
On World No Tobacco Day, May 31, international lung health groups are raising concerns over Big Tobacco’s impact on environmental health and ultimately lung health.
Read More
Idiopathic Pulmonary Fibrosis Clinical Practice Guidelines Issued
Updated clinical practice guidelines from ATS/ERS cover idiopathic pulmonary fibrosis and address progressive pulmonary fibrosis in patients with interstitial lung diseases other than IPF.
Read More
ATS/ERS PFT Standards Updated
The ATS and ERS have updated their pulmonary function tests technical standard series to address the uncertainty around the interpretation of tests.
Read More
First Ever World Bronchiectasis Day Scheduled for July 1
Global lung health organizations from the US, Europe, Australia, and Asia have established the first World Bronchiectasis Day for July 1, 2022, to raise awareness of bronchiectasis and its increased prevalence in many countries.
Read More
Philip Morris Acquisition of Vectura a ‘Dark Episode’
Healthcare organizations are concerned respiratory medication delivery technology will now be used to more effectively deliver tobacco and nicotine.
Read MoreGSK to Highlight Research at ERS 2016
GlaxoSmithKline will provide updates on research across its respiratory portfolio at the European Respiratory Society International Congress.
Read More
Out with the Old, In with the New: The ATS/ERS Standardization Statements
New guidelines emphasize the need for better educated personnel to meet the challenges of ever more complex equipment and procedures
Read More